‹ BackNewsprimary market

primary market

humanoid robo
2026-09-26 03:43:09

Humanoid robot boom runs into weak orders and valuation pressure, IT Juzi says

China’s humanoid robot sector is drawing huge amounts of capital, but IT Juzi argues the commercial picture still looks thin. In a market commentary published by MarsBit, the research outlet said primary-market investors poured 93.5 billion yuan into the segment in the first half of 2026, while companies valued above 10 billion yuan jumped from three to 22 within a year. Some firms reportedly closed four funding rounds in three months, with a new term sheet signed before money from the previous round had even arrived. The article contrasts that fundraising pace with limited real-world deployment. Global annual sales were put at roughly 22,000 units, and about 80% of sold robots were said to be used for stage shows, research and education, or data collection rather than factory lines or warehouse logistics. IT Juzi also pointed to more than 70 completed robot training grounds in China, with another 46 under construction, while average effective data collection rates remained only in the low teens. The piece said pressure is now building in public markets. Unitree, described as the first listed humanoid robot stock, surged on debut in August and then quickly lost half its value. Against a backdrop of 82 broken IPOs out of 108 Hong Kong listings this year, IT Juzi said investor sentiment has shifted from fear of missing out to concern about being trapped in overvalued deals.

240
Humanoid robot boom runs into weak orders and valuation pressure, IT Juzi says
Crypto VC Hits an Inflection Point as SAFT Arbitrage Loses Its Edge
Linera community sale falls short after raising $848,000, missing minimum target
Linera community sale raises $848,000, misses $1.5 million minimum target
primary marke
2026-09-06 04:07:11

Hard-tech mania in private markets meets sharp reversals in public trading

A commentary published by MarsBit sketches a widening split between China’s primary and secondary capital markets, using hard-tech projects and recent IPOs to show how money is being priced very differently across the two. The piece starts with a world-model startup that, according to the author, went from being a difficult, low-monetization AI bet last year to one of the hottest fundraising stories this year, with capital chasing anything tied to simulations of the physical world. The author says the project raised billions of yuan within half a year and is already discussing a new round at a valuation approaching the high hundreds of billions, a sign of intense fear of missing out in private markets. The article then broadens to listed names and the IPO queue. It cites Qingke Research data showing 5,944 equity investment cases in China in the first half of 2026, up 14.7% year over year, with total investment reaching about 565.4 billion yuan, up 31.9%. Yet, by the author’s account, roughly 90% of first-market money this year has concentrated in AI, robotics, world models, quantum technology, controllable nuclear fusion, integrated circuits and commercial aerospace. On the public-market side, several hard-tech listings are described as peaking at the open and then retreating quickly, including Unitree and Pinzhun Laser, while ChangXin Technology is presented as a contrasting case backed by much stronger earnings and lower valuation multiples. The article frames the gap as a test of how much hard-tech issuance public markets can absorb and whether “patient capital” is being practiced or merely invoked.

940
Hard-tech mania in private markets meets sharp reversals in public trading
YZi Labs
2026-09-02 05:25:32

YZi Labs’ latest residency class revives a bigger question: is it really a top-tier crypto VC?

YZi Labs unveiled the final cohort for the fourth season of EASY Residency on Aug. 26, selecting 24 early-stage projects that can each receive up to $500,000, with roughly $12 million allocated for the season. The batch is heavily tilted toward stablecoin payments, cross-border settlement, on-chain FX, credit, digital banking, institutional liquidity, AI agents, and on-chain asset management, with “global payments” named as a central investment theme. The article argues that the new cohort highlights a broader shift in how YZi Labs wants to be seen. The firm, which manages more than $1 billion and retains deep ties to Binance through its history and network, has money, reach, and distribution. RootData shows it completed 34 investment rounds over the past year, second only to Coinbase Venture. Still, raw activity does not settle the harder question of whether YZi Labs can consistently spot category leaders before the market does. According to the piece, YZi Labs has been effective at backing projects once demand is visible and then helping them scale through exchange-era advantages, BNB Chain access, and Binance-linked networks. But that same model may also define its limits. The commentary points to missed names in prediction markets and payments, a public dispute tied to the BNB Treasury Company plan with 10X Capital, and a team profile shaped by finance, consulting, and exchange growth rather than deep on-chain product instinct. The test ahead is not how many deals YZi Labs can do, but whether it can develop conviction independent of Binance and identify the next wave before consensus forms.

490
YZi Labs’ latest residency class revives a bigger question: is it really a top-tier crypto VC?
RootData says crypto private-market funding disclosures hit $596 million across 49 deals in August
DeepSeek
2026-08-25 10:43:08

Zhong Shanshan indirectly backed DeepSeek through his investment vehicle, with the stake estimated at about RMB 354 million

DeepSeek’s first financing round is drawing renewed attention as the company moves into a second round, with more details emerging about who got in early. Public ownership records cited in the report show that Zhong Shanshan, China’s richest man and founder behind the Nongfu Spring and Wantai Bio businesses, indirectly invested in DeepSeek through a chain of entities linked to Guanzi Venture Capital. Based on the structure described in the article and Tianyancha corporate data, the investment is estimated at roughly RMB 354 million. The report says DeepSeek’s first round, completed in June, included state-backed capital, market-oriented institutions, internet companies, and a RMB 5 billion commitment from CATL. It also names industrial capital from firms such as Andon Health, By-Health, and Septwolves. For Zhong, the DeepSeek deal stands out because it is described as his first move into the AI large-model segment, even though Guanzi Venture Capital had previously appeared as a pre-IPO shareholder in AI chip company Lightelligence. The article also maps a broader technology investment footprint under the Yangshengtang system, including Qiantang New Materials Laboratory and the Kunshan Gewu Zhizhi fund, both of which have been active in hard-tech areas such as new materials, photonic chips, superconducting equipment, embodied intelligence, and solid-state batteries.

1130
Zhong Shanshan indirectly backed DeepSeek through his investment vehicle, with the stake estimated at about RMB 354 million